ENPICOM HAS BEEN RECOGNIZED AS ONE OF THE 15 MOST PROMISING BIOTECH STARTUPS OF EUROPE IN 2019

ENPICOM has been recognized as one of the 15 most promising Biotech startups in Europe 2019, by StartUp City magazine. Earlier this month StartupCity Magazine published its annual list of the “15 Most Promising biotech startups in Europe – 2019”; ENPICOM was one of them.

The Startup City magazine is the leading media source for latest news and discussion topics on Tech Startups. The magazine is mainly dedicated to startups, small businesses, and entrepreneurs. StartUp City Magazine: “ENPICOM is an expanding biomedical software development company. They use computational biology to build solutions that truly matter and improve people’s lives and health. ENPICOM aims at bringing innovative products supporting the development, guidance, and monitoring of immunotherapies to the market. Their first product under development is a T-cell and B-cell receptor repertoire analysis platform”.

“It is an honor to receive this recognition, and we are devoted to continue on building and advancing our pipeline with new applications that matter to patients” says Jos Lunenberg, CEO

The original article can be accessed from: Biotech-startup